Copyright
©The Author(s) 2022.
World J Clin Cases. Jan 21, 2022; 10(3): 899-918
Published online Jan 21, 2022. doi: 10.12998/wjcc.v10.i3.899
Published online Jan 21, 2022. doi: 10.12998/wjcc.v10.i3.899
Figure 2 Fraction correct of carcinoembryonic antigen, carbohydrate antigen, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index.
1Fraction correct (FC) overall utility good; 2FC overall utility acceptable; 3FC overall utility poor. CEA: Carcinoembryonic antigen; CA19-9: Carbohydrate antigen; NLR: Neutrophil-to-lymphocyte ratio; PLR: Platelet-to-lymphocyte ratio; SII: Systemic immune-inflammation index.
- Citation: Manojlovic N, Savic G, Nikolic B, Rancic N. Dynamic monitoring of carcinoembryonic antigen, CA19-9 and inflammation-based indices in patients with advanced colorectal cancer undergoing chemotherapy. World J Clin Cases 2022; 10(3): 899-918
- URL: https://www.wjgnet.com/2307-8960/full/v10/i3/899.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i3.899